US chemical company DuPont (NYSE:DD) announced on Thursday that it has won a 2026 R&D 100 Award in the Mechanical/Materials category, for its DuPont Liveo Pharma TPE Ultra-Low Temp Tubing product.

Sponsored by R&D World Magazine, the R&D 100 Awards aim to recognise the 100 most innovative technologies of the previous year.

DuPont Liveo Pharma TPE Ultra-Low Temp Tubing is designed for biopharmaceutical processing applications that require exposure to extremely low temperatures. It is a sterilisable, weldable, and sealable thermoplastic elastomer tubing manufactured in an ISO Class 7 cleanroom. According to the company, the tubing maintains toughness and flexibility down to -86°C and offers strong resistance to bending, crushing, impact, chemicals, and burst pressure. Supported by a comprehensive regulatory and validation data package, it provides biopharma manufacturers with a high-purity solution for fluid transfer and single-use processing applications while expanding DuPont's portfolio of Liveo biopharma processing technologies.

DuPont FilmTec Fortilife XC220 Element was also named an R&D 100 Finalist. The reverse osmosis membrane technology is designed to help customers address some of the most challenging industrial water reuse, brine management, and resource recovery applications.

This year, the R&D 100 Awards received entries from eight different countries and regions and nominations were judged by more than 50 industry professionals from across the world.